Virginia Commonwealth University
Richmond, Virginia
Leslie M. Randall, M.D., MAS, FACS, is a gynecologic oncologist and the Diane Harris Wright Professor and
Director ofthe Division ofGynecologicOncology at VCU Massey Cancer Center, as well as Professorin the
Department ofObstetrics and Gynecology atthe VCUSchool of Medicine. She joined VCU in January 2020
fromtheUniversity ofCalifornia Irvine MedicalCenter,where shewas anAssociate Professor ofObstetrics and
Gynecology andDirector of Medical Education and the ACGME-accreditedGynecologicOncology Fellowship.
An accomplished clinician and skilled surgeon,Dr.Randall has expertise inminimally invasive,robotic and radical
cytoreductive procedures, including HIPEC (hyperthermic intraperitoneal chemotherapy). She has extensive
experiencewithcomplexandnovel chemotherapyregimensandclinicaltrials.Herpracticealsoencompassesthe
care of women with genetic predisposition to gynecologic cancer and those seeking fertility-sparing options.
Dr. Randall is very active in developing and leading clinical trials and hasserved asthe principal investigator
of many trials on local, national and international levels. She serves on the NRG Oncology Developmental
Therapeutics and Ovarian Cancer Committees, and the Gynecologic Oncology Group (GOG) Foundation Board of
Directors. She currently serves as Lead Cervical Cancer Clinical TrialsAdvisorfortheGOGPartners
Leadership Committee.
Dr.Randallhaspublishednumerousmanuscriptsinpeer-reviewedjournals. Sheservesontheeditorialboardof
the academic journalsGynecologyOncology Research and Practice andGynecologicOncology Reports and as a
reviewerofmanuscriptsforsixotherjournals.Sheisamemberofseveralprofessionalmedicalsocieties.
Dr.Randall earned a Bachelor of Science degree in Biotechnology and a Medical Doctorate from University of
Louisville in Kentucky,where she also completed herObstetrics andGynecology residency. She completed her
fellowship inGynecologicOncology attheUniversity of California Irvine Medical Center and obtained a Master
of Advanced Studies in Advanced Clinical Research at the University of California San Diego.
Agenus (Individual(s) Involved: Self; Clinical Condition: oncology): Consultant; Astra Zeneca (Individual(s) Involved: Self; Clinical Condition: oncology): Advisory Board, Consultant, Speaker's Bureau; Caris (Individual(s) Involved: Self; Clinical Condition: Oncology): Advisory Board; GOG Foundation (Individual(s) Involved: Self; Clinical Condition: Oncology): Advisory Board, Consultant; GSK (Individual(s) Involved: Self; Clinical Condition: oncology): Advisory Board, Consultant, Grant/Research Support, Speaker's Bureau; Merck (Individual(s) Involved: Self; Clinical Condition: Oncology): Advisory Board, Consultant, Grant/Research Support, Speaker's Bureau
Wednesday, April 27, 2022
2:35 PM – 3:25 PM
Thursday, April 28, 2022
1:55 PM – 3:30 PM
Thursday, April 28, 2022
1:55 PM – 2:00 PM
Thursday, April 28, 2022
3:00 PM – 3:30 PM
Friday, April 29, 2022
9:00 AM – 10:00 AM
Friday, April 29, 2022
9:05 AM – 9:20 AM
Friday, April 29, 2022
9:35 AM – 10:00 AM